In the October 2017 edition of the Network Update, Empire announced a new coverage guideline, Cervical Cancer Screening Using Cytology and Human Papillomavirus Testing (CG-MED-53) to be effective January 1, 2018. Please be advised that CG-MED-53 was not implemented. 



Featured In:
June 2018 Empire Provider Newsletter